United States Liquid Biopsy Market Expected to Grow at Double-Digit CAGR

SAN FRANCISCO - Jan. 4, 2023 - PRLog -- Over the past ten years, liquid biopsy has been the focus of significant research to create a less intrusive and more precise customised therapy. Additionally, liquid biopsies are gaining popularity in the US due to its sophisticated nature, which includes a quick turnaround time, feasibility, and the ability to perform early cancer screening.

Increasing Healthcare Spending: Approximately 85% of national health expenditures are for personal health care. In 2019 around USD 3,207 billion in current (nominal currency) spending on personal healthcare were witnessed.

Increasing Government Initiative towards Cancer Research: The Health Resources and Services Administration of the U.S. Department of Health and Human Services (HHS) has announced the availability of USD 5 million for community health centers to promote equitable access to potentially life-saving cancer screenings.

Performance by Type: Circulation Tumor Cells (CTCs) account for the major market share in US Liquid Biopsy Market in 2021.

The non-invasiveness of liquid biopsy is the main element influencing its great demand among medical professionals. It is less invasive, more convenient, and quicker for patients than other treatments because just 5 milliliters of blood are required.

Cancer Cases in the United States: The United States witnessed around 1,898,160 new cancer cases and 608,570 cancer-related deaths in 2021. Because of decreased smoking and advancements in early identification and treatment, the cancer death rate has decreased steadily since 1991. The number of cancer survivors in the United States is projected to increase by 24.4% by 2032, reaching 22.5 million. Currently, there are 18 million cancer survivors in the United States. These survivors represent approximately 5.4% of the entire population.

Future Growth Outlook: Liquid Biopsy is an emerging technology with potential application in screening and early diagnosis of lung cancer. The scope of growth increases with its minimal invasive feature and rising investments in R&D. Makreo Research predicts the United States liquid biopsy market will grow at double digit CAGR in next five years.

Check out our Blog- https://69b6.short.gy/Liquid-Biopsy-Market

The above facts have been taken from the recent publication of Makreo Research titled "United States Liquid Biopsy Market Revenue and Forecast to 2028". This is a detailed study that identify the present adoption rate of the newly introduced biopsy in the US market and also highlights future expected growth. The report offers comprehensive analysis of the market trends and future prospects in relation with macro-economic shifts and players operating in this space.

For more information about this report visit
United States Liquid Biopsy Market Forecast to 2028: Size, Share, Revenue and Growth Analysis (https://www.makreo.com/report/united-states-liquid-biopsy...)

Contact us
Makreo Research and Consulting
Send us query at info@makreo.com